SARS-CoV-2感染重症病例多器官病理实验室标志物及不良结局(系统评价)

N. A. Konyshko, L. I. Volynets, G. S. Konyshko
{"title":"SARS-CoV-2感染重症病例多器官病理实验室标志物及不良结局(系统评价)","authors":"N. A. Konyshko, L. I. Volynets, G. S. Konyshko","doi":"10.22625/2072-6732-2023-15-3-29-38","DOIUrl":null,"url":null,"abstract":"The aim of the review: to present up-to-date scientifically based information about the laboratory parameters of patients associated with severe SARS-CoV-2 infection and internal organ damage. Materials and methods: full-text publications of clinical, randomized and cohort studies, systematic reviews and meta-analyses from scientific databases PubMed, Elsevier, Scopus, Google Scholar, E-library for the period from 2019 to 2022 were analyzed. Results. Specific biomarkers were identified, including inflammatory and immunological parameters (C-reactive protein, procalcitonin, IL6), hematological (number of lymphocytes and neutrophils, NLR, D-dimer, ferritin, RDW), myocardial (troponin, creatinekinase-MB, myoglobin), hepatic (AST, ALT, total bilirubin, albumin) and characterizing lung injury (KL-6), which can be used for risk stratification, as prognostic biomarkers of adverse clinical consequences, including death in patients with COVID-19. The studies demonstrated new biomarkers of inflammatory and systemic manifestations of COVID19: procalcitonin, calprotectin and presepsin.","PeriodicalId":52123,"journal":{"name":"Jurnal Infektologii","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Laboratory markers of multiple organ pathology in severe cases and adverse outcomes of SARS-CoV-2 infection (systematic review)\",\"authors\":\"N. A. Konyshko, L. I. Volynets, G. S. Konyshko\",\"doi\":\"10.22625/2072-6732-2023-15-3-29-38\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The aim of the review: to present up-to-date scientifically based information about the laboratory parameters of patients associated with severe SARS-CoV-2 infection and internal organ damage. Materials and methods: full-text publications of clinical, randomized and cohort studies, systematic reviews and meta-analyses from scientific databases PubMed, Elsevier, Scopus, Google Scholar, E-library for the period from 2019 to 2022 were analyzed. Results. Specific biomarkers were identified, including inflammatory and immunological parameters (C-reactive protein, procalcitonin, IL6), hematological (number of lymphocytes and neutrophils, NLR, D-dimer, ferritin, RDW), myocardial (troponin, creatinekinase-MB, myoglobin), hepatic (AST, ALT, total bilirubin, albumin) and characterizing lung injury (KL-6), which can be used for risk stratification, as prognostic biomarkers of adverse clinical consequences, including death in patients with COVID-19. The studies demonstrated new biomarkers of inflammatory and systemic manifestations of COVID19: procalcitonin, calprotectin and presepsin.\",\"PeriodicalId\":52123,\"journal\":{\"name\":\"Jurnal Infektologii\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Infektologii\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22625/2072-6732-2023-15-3-29-38\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Infektologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22625/2072-6732-2023-15-3-29-38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

该综述的目的是:提供与严重SARS-CoV-2感染和内脏损伤相关的患者实验室参数的最新科学信息。材料和方法:分析2019年至2022年期间来自PubMed、Elsevier、Scopus、Google Scholar、E-library等科学数据库的临床、随机和队列研究全文、系统评价和荟萃分析。结果。确定了特异性生物标志物,包括炎症和免疫参数(c反应蛋白、降钙素原、IL6)、血液学参数(淋巴细胞和中性粒细胞数量、NLR、d -二聚体、铁蛋白、RDW)、心肌参数(肌钙蛋白、肌动激酶mb、肌红蛋白)、肝脏参数(AST、ALT、总胆红素、白蛋白)和肺损伤特征(KL-6),这些可用于风险分层,作为COVID-19患者不良临床后果(包括死亡)的预后生物标志物。这些研究发现了covid - 19炎症和全身表现的新生物标志物:降钙素原、钙保护素和高血压素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Laboratory markers of multiple organ pathology in severe cases and adverse outcomes of SARS-CoV-2 infection (systematic review)
The aim of the review: to present up-to-date scientifically based information about the laboratory parameters of patients associated with severe SARS-CoV-2 infection and internal organ damage. Materials and methods: full-text publications of clinical, randomized and cohort studies, systematic reviews and meta-analyses from scientific databases PubMed, Elsevier, Scopus, Google Scholar, E-library for the period from 2019 to 2022 were analyzed. Results. Specific biomarkers were identified, including inflammatory and immunological parameters (C-reactive protein, procalcitonin, IL6), hematological (number of lymphocytes and neutrophils, NLR, D-dimer, ferritin, RDW), myocardial (troponin, creatinekinase-MB, myoglobin), hepatic (AST, ALT, total bilirubin, albumin) and characterizing lung injury (KL-6), which can be used for risk stratification, as prognostic biomarkers of adverse clinical consequences, including death in patients with COVID-19. The studies demonstrated new biomarkers of inflammatory and systemic manifestations of COVID19: procalcitonin, calprotectin and presepsin.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Jurnal Infektologii
Jurnal Infektologii Medicine-Infectious Diseases
CiteScore
0.80
自引率
0.00%
发文量
52
审稿时长
8 weeks
期刊介绍: The purposes of the journal are to describe modern achievements in the study of infectious diseases, and in related sciences as well; to promote the exchange of clinical experience among the experts; to publish the results of clinical research of medical products and medical equipment; to give the information on medical congresses on infectious diseases as well as other significant events in the field of modern infectology in our country and abroad.
期刊最新文献
Listeriosis in the third trimester of pregnancy: the course of the disease and outcomes for the mother and fetus Comparative characteristics of pneumonia caused by <i>Mycoplasma pneumoniae</i> in children Durability of first-line antiretroviral treatment in the Russian Federation: retrospective study An artificial intelligence approach for prognosis of COVID-19 course in hospitalized patients Clinical and epidemiological characteristics of D hepatitis В and delta in the Republic of Dagestan
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1